If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 101 - 110 of 294
A Phase 1 Multicenter Dose Escalation and Dose Expansion Study of Antibody-Drug Conjugate MYTX-011 in Subjects with Non-Small Cell Lung Cancer
A Phase 1 Study of MYTX-011 in Subjects with NSCLC
Protocol No
MYTHIC-MYTX-011-01
Categories
A Phase 1, First-in-human (FIH), Dose-finding and Expansion Study to Evaluate the Safety and Tolerability of XmAb808 in Combination with Pembrolizumab in Selected Advanced Solid Tumors
A Phase 1 Study of XmAb808 in Select Advanced Solid Tumors
Protocol No
XENCOR-XMAB808-01
Categories
Cancer,
Colorectal,
Early Phase/Multiple Disease Site Cancers,
Thoracic Cancers,
Skin Cancers,
Prostate and Urologic Cancers,
Head and Neck Cancers,
Gynecologic Cancers,
Gastrointestinal Cancers,
Breast Cancers,
Lung,
Melanoma, Skin,
Bladder,
Prostate,
Kidney,
Lip, Oral Cavity and Pharynx,
Larynx,
Ovary
TES To Remediate Phonological Impairments After Stroke
TES for Language Impairment
Protocol No
NEURO-IIT-SHAH-TES
Categories
Examination of Motor Unit Alterations in Acute and Subacute Stroke
Motor Unit Alterations in Acute and Subacute Stroke
Protocol No
NEURO-IIT-LI-MOTOR-UNIT-ALT
Categories
A Randomized Clinical Trial of tDCS to Remediate Phonological Impairment in Aphasia
HD-tDCS for Phonological Impairment in Aphasia
Protocol No
NEURO-IIT-PILLAY-ALF-TDCS
Parkinson's Foundation PD GENEration Genetic Registry
Parkinson's Foundation PD GENEration Genetic Registry
Protocol No
NEURO-PF-PDGENE
A Phase 1, Open-Label, Multicenter, Dose Escalation Study of SGR-1505 as Monotherapy in Patients with Mature B-Cell Malignancies
A Phase 1 Study if SGR-1505 in Patients with B-Cell Malignancies
Protocol No
SCHRODINGER-SGR-1505-101
Categories
A Randomized, Double-Blind, Placebo-Controlled Trial of IkT-148009 in Untreated Parkinson's Disease
IkT-148009 in Untreated Parkinson's Disease
Protocol No
NEURO-INHIBIKASE-IKT-148009
Prospective Observational Study of Clinical Utility of Envisia Genomic Classifier in Patients With Undiagnosed Interstitial Lung Disease
Prospective Observational Study of Clinical Utility of Envisia Genomic Classifier in Patients With Undiagnosed Interstitial Lung Disease
Protocol No
PULM-VERACYTE-ENVISIA-ILD
Categories
A Randomized Phase II Trial of Consolidation Therapy Following CD19 CAR T-Cell Treatment for Relapsed/Refractory Diffuse Large B-Cell Lymphoma or Grade IIIB Follicular Lymphoma
To find out if this approach is better or worse than the usual approach for DLBCL patients receiving CAR T-cell therapy. The usual approach for Relapsed/Refractory DLBCL patients is follow-up visits with no further therapy.
Protocol No
SWOG-S2114
Categories